How best to develop a #RealisticVirtualEarthFor, a #RVEforHypothesisTesting - eg think a forked #GoogleStreetView with #TimeSlider & with #Gpegman becoming our #
https://share.gemini.google/
How best to develop a #RealisticVirtualEarthFor, a #RVEforHypothesisTesting - eg think a forked #GoogleStreetView with #TimeSlider & with #Gpegman becoming our #AvatarAgentElectronicMedicalRecords or #DigitalHealthTwins ?https://t.co/riX0twp9wz & see: https://t.co/vNHkatL2Zc ~
— WorldUnivandSch (@WorldUnivAndSch) October 3, 2026
https://x.com/WorldUnivAndSch/
and to publish papers too in a scientific press -
https://x.com/WUaSPress/
To build a Realistic Virtual Earth (RVE) for Hypothesis Testing—combining spatial geospatial rendering, time-slider environmental contexts, and personal digital health twins—you can leverage Google Cloud’s geospatial stack, Google DeepMind’s biological AI tools, and medical language models.
Part 1: System Architecture for the RVE Platform
+----------------------------- ------------------------------ ------------------------+
| RVE UI LAYER |
| CesiumJS / Unreal Engine 5 <---> Google Photorealistic 3D Tiles API |
| Sidebar UI: 3Dmol.js / NGL Viewer (Molecular) + FHIR EMR Dashboard (Avatar Agent)|
+----------------------------- ------------------------------ ------------------------+
|
v
+----------------------------- ------------------------------ ------------------------+
| RVE CORE PLATFORM |
| 1. Geospatial Engine: Google Earth Engine (Historical Time-Slider & Climate) |
| 2. Agent Framework: Avatar Pegman (Digital Twin / OMOP CDM / FHIR EMR) |
| 3. Orchestration: Google Cloud Vertex AI Pipelines |
+----------------------------- ------------------------------ ------------------------+
|
v
+----------------------------- ------------------------------ ------------------------+
| GOOGLE AI / ML SUITE |
| * Gemini 1.5 Pro / MedLM: Literature Synthesis & Experimental Design |
| * AlphaFold 3 / AlphaProteo: Molecular Docking & Binding Affinity Predictions |
| * Differential Equation / Neural ODE Models: Cellular Pathways & Dynamics |
+----------------------------- ------------------------------ ------------------------+
1. Spatial Geospatial & Temporal Rendering Engine
Base Viewer: Fork an open-source 3D geospatial engine such as CesiumJS or Unreal Engine 5 (via the Cesium plugin) integrated with Google Photorealistic 3D Tiles API.
Temporal Layer (Time Slider): Connect the temporal slider to Google Earth Engine API and historical street-level imagery archives. This supplies time-series environmental data (e.g., air quality indices, temperature variations, UV index, urban greenspace density) mapped to specific geographic coordinates.
2. Avatar Pegman as an EMR-Linked Digital Health Twin
Data Standard: Map the avatar agent to standard HL7 FHIR resources or an OMOP Common Data Model (CDM) schema.
Spatial Agent Logic: Pegman acts as an autonomous agent representing a cohort or individual. As Pegman moves through space and time on the RVE, environmental exposures dynamically update the agent's physiological baseline parameters.
3. Google AI / ML Middleware Integration
Vertex AI Pipelines: Orchestrate workflows between spatial queries, biological modeling, and inference tasks.
Gemini / MedLM: Drive automated literature retrieval, hypothesis synthesis, and natural-language query interfaces in the sidebar.
AlphaFold 3 & AlphaProteo: Simulate 3D protein structures, ligand-receptor binding interactions, and custom biological agent modifications.
Part 2: Testing the Longevity Hormone Hypothesis
Here is a step-by-step workflow using Klotho (a well-established lifespan-extending hormone) targeting FGF21 / FGFR1c-Klotho receptor complexes in the brain’s choroid plexus and hippocampus.
[Phase 1: Lit Review] ---> [Phase 2: UI Context Integration] ---> [Phase 3: Multi-Scale Brain Mapping]
|
[Phase 6: In-Vivo Protocol] <--- [Phase 5: In-Silico Experiment] <----------------+
Step 1: AI Scientific Literature Review (Gemini / MedLM Agent)
The agent executes an automated pipeline querying PubMed, PMC, and bioRxiv to extract molecular pathways, target receptors, and dosage-response metrics.
Key Extracted Synthesis:
Hormone Target: Recombinant $\alpha$-Klotho ($\text{sKL}$).
Primary Brain Target: Hippocampal dentate gyrus (neural stem cell niche) and choroid plexus.
Receptor Mechanism: Forms a binary complex with FGFR1c, triggering the extracellular signal-regulated kinase ($\text{ERK1/2}$) and $\text{Akt}$ phosphorylation cascades, upregulating $\text{NMDAR}$ subunit GluN2B, and decreasing neuroinflammation ($\text{TNF-}\alpha$, $\text{IL-6}$).
Step 2: Sidebar UI Integration (Spatial & Biological Mapping)
When selecting Pegman or clicking a target brain region in the RVE interface:
Left Main Window: RVE environment (e.g., Street View at a specific geographic location with environmental stress sliders like particulate matter $\text{PM}_{2.5}$).
Right Sidebar:
Molecular View: Embedded 3Dmol.js or NGL Viewer showing the interactive 3D co-crystal structure of Klotho bound to FGFR1c (PDB ID derived via AlphaFold 3).
Spatial Health Panel: Real-time physiological telemetry of the Pegman avatar (e.g., baseline plasma Klotho concentration $c_0 = 500 \text{ pg/mL}$, biological age vs. chronological age).
Step 3: Multi-Scale Brain Mapping (Molecular to Cellular Levels)
| Scale | Biological Domain | Mathematical / Machine Learning Representation |
| Molecular | Hormone-Receptor Binding Kinetics | Rate equations: $\frac{d[RL]}{dt} = k_{\text{on}} [R][L] - k_{\text{off}} [RL]$ with $K_d = \frac{k_{\text{off}}}{k_{\ |
| Cellular | Neural Stem Cell Proliferation & Microglial Activation | Systems biology differential equations (ODE/SDE) predicting $\text{p16}^{\text{INK4a}}$ senescence reduction |
| Tissue / Organ | Hippocampal Long-Term Potentiation (LTP) & Synaptic Density | Neural network surrogate modeling synaptic transmission efficiency ($V_m$) |
| Organism / Population | Survival Function & Cox Proportional Hazard | Survival model: $h(t \mid X) = h_0(t) \exp(\beta_1 X_{\text{Klotho}} + \beta_2 X_{\text{environment}})$ |
Step 4: Designing and Executing the Virtual (In-Silico) Experiment
A. Virtual Cohort & Experimental Groups
Define two avatar agent populations within the RVE across environmental conditions (e.g., low vs. high urban pollution exposure):
Control Group ($N=1,000$): Vehicle administration ($c_{\text{Klotho}} = \text{baseline}$).
Treatment Group ($N=1,000$): Systemic or central administration of elevated $\alpha$-Klotho ($c_{\text{Klotho}} = 2.5 \times \text{baseline}$).
B. Simulation Execution
Molecular Dynamics (AlphaFold 3 / GROMACS): Calculate binding free energy ($\Delta G_{\text{bind}}$) of Klotho variants to brain FGFR1c receptors.
Cellular Pathway Simulation: Integrate drug delivery kinetics across the Blood-Brain Barrier (BBB) into a differential kinetic solver:
$$\frac{d[\text{p-ERK}]}{dt} = \frac{V_{\max} \cdot [RL]}{K_m + [RL]} - k_{\text{dephos}} [\text{p-ERK}]$$Lifespan Acceleration Simulation: Project survival curves using a Monte Carlo Markov Chain (MCMC) engine over a virtual 30-month rodent equivalent timeframe.
100% |-------------\
| \=== Treatment (Klotho Boosted)
Survival | \--- Control
Rate | \
0% +----------------------------- ----->
0 15 30 Months
Step 5: Translating Virtual Results into an In-Vivo Protocol
Based on the virtual experiment yielding a statistically significant hazard ratio reduction ($\text{HR} = 0.74, p < 0.001$), the RVE exports a laboratory-ready in vivo translation guide:
============================== ============================== =======================
IN-VIVO TRANSLATIONAL PROTOCOL OUTPUT
============================== ============================== =======================
1. ANIMAL MODEL & SAMPLE SIZE
* Species: C57BL/6J Mice (Aged 18 months, human equivalent ~60 years).
* Sample Size: N = 40 per arm (20 Male, 20 Female) powered for 80% beta at alpha=0.05.
2. DOSAGE & ADMINISTRATION ROUTE
* Compound: Recombinant α-Klotho protein.
* Route: Intranasal administration (to bypass BBB and target olfactory bulb / hippocampus).
* Dose: 10 µg/kg body weight, administered twice weekly for 4 months.
3. PRIMARY & SECONDARY ENDPOINTS
* Primary Endpoint: Median lifespan extension and Kaplan-Meier survival curves.
* Secondary Biological Biomarkers:
- Western blot / ELISA: Brain p-ERK1/2 to ERK ratio and GluN2B expression in hippocampus.
- Immunohistochemistry: Ki-67+ and DCX+ neuroblasts in dentate gyrus (neurogenesis).
- Single-cell RNA-seq: Reduction of senescent cell markers (p16INK4a, p21) in microglia.
4. BEHAVIORAL & COGNITIVE ASSAYS
* Morris Water Maze & Novel Object Recognition at Months 1, 2, and 4 post-treatment.
5. SAFETY BOUNDS & TOXICOLOGY ALERTS
* Monitor serum calcium and phosphate levels bi-weekly (to detect potential hyperphosphatemia).
============================== ============================== =======================- Scott GK MacLeod
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
1) non-profit 501(c)(3) Public Charity
building on CC-4 licensed MIT OCW in 7 languages -
http://
2) for profit general stock company WUaS Corporation in CA - http://
- wuas_ceo@
https://wiki.
World University & School Innovation Research -
- http://scottmacleod.com
- https://twitter.com/
- https://x.com/Q_
- http://www.linkedin.com/in/
- https://twitter.com/
- https://scott-macleod.
- https://
* *
And how to do this building on developing a realistic virtual earth for aging reversal and extreme longevity genetic drug therapies beginning with the Harbin Hot Springs' gatehouse and its 3 dates presently - eg with AltosLabs in Palo Alto ?
See:
Dear George (Church - gchurch@genetics.med.harvard.
Founder, President, CEO & Professor
at / of best STEAM CC licensed OCW, Wiki,
World University & School (WUaS)
- USPS US Post Office, PO Box 132, General Delivery, Canyon, CA 94516
* * * *
Schisandra chinensis: How. best to develop a realistic virtual earth - eg think a forked Google Street View with time slider & with pegman becoming our avatar agent electronic medical records, digital health twins - for scientific hypothesis testing ?
At #HarvardAgingResearch & #HarvardDrugDiscovery conf 10/1-10/3/26
https://x.com/WorldUnivAndSch/
Greetings !
*
Leanne, George (& Ting Wu),
Brainstorming, how best for your Chinese company and team and colleagues in Shanghai and all over to add your iterating longevity research to a realistic virtual earth for extreme longevity + ?And regarding - https://scott-macleod.blogspot.com/2026/09/ schisandra-chinensis.html - Saturday, October 3, 2026
Schisandra chinensis: How. best to develop a realistic virtual earth - eg think a forked Google Street View with time slider & with pegman becoming our avatar agent electronic medical records, digital health twins - for scientific hypothesis testing + and different cultures and languages sharing their research and science, eg of longevity and eg aging reversal potentially too and re https://scott-macleod.blogspot.com/2026/09/ schisandra-chinensis.html ?
Best regards, Scott
leanneye@cngen.com
ggyy11@163 comScottPS10/3 - Harvard ARDD Aging Research and Drug Development conference 10/1/26-10/3/26 in the TreeHouse in Allston, MAAnd Greetings !Great to meet and talk with you just now at Harvard AARD, and regarding also building out #AvatarAgentElectronicHealthRec ords as #DigitalTwins, planned in a #RealisticVirtualEarth (and think Google Street View with time slider with Pegman becoming #AvatarAgentEHR) and as World University and School seeks to code for all 7.9 billion people on the planet for #AvatarAgentEHR, and for aging reversal and extreme longevity genetic drug therapies emerging, and from here - https://wiki. worlduniversityandschool.org/ wiki/You_at_World_University. Here are someWorld University and School, building on MIT OCW in 7 languages, Harvard AARD goals, that is for the Harvard Aging Research and Drug Development conference 10/1/26-10/3/26 in the TreeHouse in Allston, MA :these include1Develop 3 WUaS aging reversal OSK pharmaceutical gene drug therapies initially with research, and then produce and manufacture them & with a realistic virtual earth for OSK, a digital-physical #RVEforGenetics on the digital or in-silico side - and in collaboration with possibly 3 different companies too (initially) ...that would all successfully become FDA approved ...and then upload them to our body minds via the eRapid Fouling Resistant sensor or similar -#eRapidFoulingResistantSensor-https://wyss.harvard.edu/ technology/erapid-multiplexed- electrochemical-sensors-for- fast-accurate-portable- diagnostics/ WITH #AgingReversal & #ExtremeLongevity # AvatarAgentElectronicHealthRec ords or with a vaccine ...or via smartwatches with a skin patch or similar, and/or smartphones,or drug/medicine.Best regards,ScottPSJust asked Gemini -What are 3 potential ways that yamanaka factors re OSK via epigenetic reprogramming might even be turned into genetic drug therapies to reverse aging and also extend human lifespan to beyond 150 years?On Sat, Oct 3, 2026 at 5:09 PM Scott MacLeod <sgkmacleod@worlduniversityandschool.org> wrote: Nice to meet youLeanne Yeggyy11@163 comScott
*
https://www.harvardmagazine.com/2017/12/rare-plants-in-china
https://en.wikipedia.org/wiki/Schisandra
https://en.wikipedia.org/wiki/Schisandra_chinensis
....
No comments:
Post a Comment